City Holding Co. Has $6.18 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

City Holding Co. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,222 shares of the healthcare conglomerate's stock after purchasing an additional 522 shares during the period. UnitedHealth Group accounts for about 0.9% of City Holding Co.'s investment portfolio, making the stock its 26th largest position. City Holding Co.'s holdings in UnitedHealth Group were worth $6,182,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. M&T Bank Corp raised its holdings in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after purchasing an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC lifted its position in shares of UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after buying an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. increased its holdings in shares of UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new stake in UnitedHealth Group in the 3rd quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC raised its position in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after purchasing an additional 1,051 shares during the period. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Oppenheimer boosted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a report on Wednesday, October 16th. UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Finally, Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $627.74.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE UNH traded down $0.56 during mid-day trading on Monday, hitting $510.03. The company's stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company's fifty day simple moving average is $549.37 and its 200-day simple moving average is $563.70. The stock has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The firm's quarterly revenue was up 6.8% on a year-over-year basis. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.